ALBAN CARLOS 4
4 · SpringWorks Therapeutics, Inc. · Filed Jul 15, 2022
Insider Transaction Report
Form 4
ALBAN CARLOS
Director
Transactions
- Award
Common Stock
2022-07-14+10,058→ 10,058 total - Award
Stock Option (Right to Buy)
2022-07-14+30,160→ 30,160 totalExercise: $28.93Exp: 2032-07-14→ Common Stock (30,160 underlying)
Footnotes (3)
- [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer. The RSUs shall vest in three (3) equal annual installments following July 14, 2022, subject to continued service to the Issuer by the Reporting Person.
- [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer.
- [F3]The options shall vest in equal monthly installments over 36 months following July 14, 2022, subject to continued service to the Issuer by the Reporting Person.